Bliss GVS Pharma Ltd NSE:BLISSGVS:
BLISS GVS PHARMA LTD SEPT-QUARTER CONSOL NET PROFIT 272.5 MILLION RUPEES
BLISS GVS PHARMA LTD SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 2.44 BILLION RUPEES
Bliss GVS Pharma Sept-Quarter Consol Net Profit 272.5 Million Rupees
Bliss GVS Pharma Limited on 6ix
Story so far
Earlier from Bliss GVS Pharma
- Bliss Gvs Pharma Receives Tax Demand Of 166.9 Million Rupees From Tax Department
- Bliss GVS Pharma Ltd - Appoints Narsimha Shibroor Kamath As CEO
- BLISSGVS: Strong Q1 FY26 growth in revenue and profit, with key subsidiary divestment completed
- Bliss GVS Pharma June-Quarter Consol Net Profit 430.4 Million Rupees
- Bliss GVS Pharma Gets Show Cause From Tax Department Over Recovery Of Refund Of 66.4 Million Rupees
Later from Bliss GVS Pharma
- Bliss GVS Pharma Incorporates Theralife Pharma In Kenya
- Bliss GVS Pharma board approves appointment of S.N. Kamath as Managing Director
- BLISSGVS: Q3 FY26 net profit reached ₹2,477.91 lakh; interim dividend of 0.50 paisa per share declared
- BLISSGVS: Double-digit revenue and profit growth, strong margins, and expansion in global markets
- Anupam Rasayan enters formulations business with ₹1,369 cr Bliss GVS Pharma acquisition
Follow Bliss GVS Pharma into a list and get an email when it puts out news.
Follow Bliss GVS Pharma